Monday, 13 November 2017

Duchenne MD Exon-skipping Therapy Is Now in Phase 1 Trial

Duchenne MD Exon-skipping Therapy Is Now in Phase 1 Trial: "Wave Life Sciences has started a Phase 1 clinical trial of a treatment for a gene malfunction linked to the most common form of Duchenne muscular dystrophy."



'via Blog this'

No comments:

Post a Comment